Many other signaling pathways, such as NF-κB, TGF-β, and Notch signaling, are involved in breast cancer cell growth and development [48,49,50] and may therefore be involved in or affected by RF16 treatment. This evidence concerns the gene NFKB1 and breast carcinoma.